GO
Loading...

Enter multiple symbols separated by commas

Stocks GlaxoSmithKline PLC

More

  • Fed meeting may bring more volatility than expected Wednesday, 29 Jul 2015 | 6:44 AM ET
    Traders work on the floor of the New York Stock Exchange.

    No matter how much it tries to avoid it, the Fed could get markets spinning on a fresh round of rate hike speculation Wednesday.

  • Fed statement may bring more volatility than expected Wednesday, 29 Jul 2015 | 6:02 AM ET
    Traders work on the floor of the New York Stock Exchange.

    No matter how much it tries to avoid it, the Fed could get markets spinning on a fresh round of rate hike speculation Wednesday.

  • Top trades to go: Earnings edition Tuesday, 28 Jul 2015 | 1:43 PM ET

    The "Halftime Report" traders give their trades on earnings for the second half.

  • After a week dominated by U.S. quarterly results, it's time for Europe's earnings season to get into full swing, and so far the signs are upbeat.

  • Minefield for market with Fed, earnings, commodities Monday, 27 Jul 2015 | 8:08 AM ET
    An oil trader works on the floor of the New York Mercantile Exchange.

    The Fed meets next week, but a commodities meltdown and earnings season are adding to concerns about global growth and may steal some of its thunder.

  • Allergan buys Naurex for $560M as deal talk swirls Sunday, 26 Jul 2015 | 11:20 AM ET
    A clinical technician holds a syringe and a vial of Allergan Botox, produced by Allergan.

    Allergan is considering a breakup of the company into two businesses, a person familiar with the matter told Reuters on Friday.

  • Early movers: CI, AMZN, SAVE, BIIB, MCO, T & more Friday, 24 Jul 2015 | 7:54 AM ET

    Some of the names on the move ahead of the open.

  • *EU regulators back GSK's Mosquirix for babies in Africa. LONDON, July 24- The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it as safe and effective to use in babies in Africa at risk of the mosquito-borne disease. Mosquirix, also known as RTS, S and part-funded by the Bill& Melinda Gates Foundation, will now...

  • LONDON, July 24- The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it should be licensed for use in babies in Africa at risk of the mosquito-borne disease. Recommendations for a drug licence made by the European Medicines Agency are normally endorsed by the European Commission within a couple of...

  • *Vaccine developed by GlaxoSmithKline for babies in Africa. LONDON, July 24- The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it should be licensed for use in babies in Africa at risk of the mosquito-borne disease. The shot, called RTS, S or Mosquirix and developed by British drugmaker GlaxoSmithKline...

  • July 21- Novavax Inc said its experimental Ebola vaccine induced a substantial immune response to the deadly infection in an early-stage trial involving 230 healthy adults. Potential partners include the Biomedical Advanced Research and Development Authority, a division of U.S. Department of Health and Human Services, which Novavax is already working...

  • Novavax rises on promising Ebola vaccine trial Tuesday, 21 Jul 2015 | 9:39 AM ET
    In this handout from the Center for Disease Control, a colorized transmission electron micrograph (TEM) of a Ebola virus virion is seen.

    Novavax shares rose at Tuesday's market open after the bio-pharmaceutical firm said its Ebola vaccine showed promising early results.

  • July 21- Novavax Inc said its experimental Ebola vaccine induced a substantial immune response to the deadly infection in an early-stage trial involving 230 healthy adults. Vaccines being developed by Bavarian Nordic, GlaxoSmithKline and Johnson& Johnson have entered mid-stage studies. Gaithersburg, Maryland- based Novavax's shares have risen more than...

  • DUBLIN, July 16- Britain's Immunocore completed Europe's largest ever financing round by a private life sciences company on Thursday, raising $320 million from investors including Eli Lilly& Co, Malin and Woodford Investment Management. The investment by some of the healthcare sector's "most highly regarded international institutions" is another...

  • MUMBAI, July 16- India has extended price caps to an additional 39 drugs ranging from commonly used diabetes treatments to antibiotics, in the government's latest effort to improve the affordability of medicines. Wide-ranging price cuts over the past year have hit several drugmakers in India and have been opposed by many in the industry, who say drug prices in...

  • LONDON, July 14- It's a showpiece drug that has the potential to end a disease that kills half a million African children a year. Backed by billionaire philanthropist Bill Gates and developed by GlaxoSmithKline, the vaccine-- called RTS, S or Mosquirix-- is being assessed by regulators and global health authorities. But it's a very complicated vaccine, so the...

  • BEIJING, July 9- Chinese authorities have detained about half a dozen former employees of Tencent Holdings Ltd, the country's biggest social network and online media company, as part of a graft investigation following an internal company probe, Tencent said late on Thursday. Amid a continuing crackdown on corruption by Chinese President Xi Jinping, Tencent...

  • LONDON, July 2- China will receive cut-price supplies of GlaxoSmithKline's new HIV drug Tivicay, following a deal for Shanghai- based Desano Pharmaceuticals to become an additional manufacturer of the medicine's active ingredient. The collaboration between GSK's HIV unit ViiV Healthcare and Desano marks an improvement in the business climate for the...

  • Pfizer Inc, the largest U.S. drugmaker, for example reported more than $234.2 million in research payments and another $53.3 million in general payments. John Diliberti, a pediatric geneticist from Illinois, collected nearly $447,000 from Pfizer in consulting fees last year, the biggest single payment to an individual doctor by the drugmaker.

  • Philip Morris International Inc has hired more than 400 scientists and technical staff at its research facility in Neuchatel, Switzerland, including toxicologists, chemists, biologists, biostatisticians and regulatory affairs experts. Altria Group Inc, makers of Marlboro, has recruited dozens of scientific and healthcare experts, as have independent...